Writing the Future of Biologics using the Twist Biopharma Library of Libraries

alt text
Presented by
Aaron Sato, PhD
Aaron Sato, PhD
Twist Biopharma
RECORDED AT Antibody Engineering & Therapeutics 2022

Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery libraries including both (1) highly diverse synthetic naïve antibody phage display libraries and (2) target class specific antibody phage display libraries against difficult-to-drug targets.  In this talk, Aaron Sato, CSO, will present several POC data on each member of their Library of Libraries.  For some of the targets, the power of selecting multiple libraries against each target will be highlighted.

Share your details to Watch the Webinar